Le Lézard
Classified in: Business
Subject: ATY

VRX Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors



BOSTON, Oct. 5, 2017 /PRNewswire/ -- Kyros Law Offices is alerting investors of Valeant Pharmaceuticals Intl (NYSE: VRX)  that it is investigating legal claims against the company for possible securities fraud violations committed by Valeant Pharmaceuticals Intl (NYSE: VRX).

Valeant Pharmaceuticals Intl (NYSE: VRX)  investors that have invested over $100,000 before March 2016 are urged to contact our law firm immediately to protect their rights. Visit our VRX Lawsuit website or call 1-800-934-2921 to speak to someone about your case.

The investigation concerns possible violations of securities law committed by Valeant Pharmaceuticals Intl (NYSE: VRX)  management that has led to significant losses to investors. Recent lawsuits filed against the company allege that Valeant Pharmaceuticals Intl (NYSE: VRX)  may have improperly used a pharmacy network to artificially increase sales for their drugs.

In February 2016, Valeant Pharmaceuticals Intl (NYSE: VRX) announced it would restate its financial results, citing issues with revenue recognition stemming from sales from a specific pharmacy network. That same month, the company came under SEC investigation. During this time, the stock price of VRX dropped significantly, with the share prices dropping more than 90%.

Kyros Law has been recently contacted by numerous unhappy VRX investors with hundreds of thousands of dollars invested in the company. The law firm is dedicated to fighting for the rights of these investors, and other investors that have lost money in VRX stock.

Kyros Law Offices urges Valeant Pharmaceuticals Intl (NYSE: VRX)  investors that invested more than $100,000 prior to March 2016 to contact our law firm immediately to protect their rights. Visit our VRX Lawsuit website or call 1-800-934-2921 to find out if you have a case.

Kyros Law specializes in a wide range of complex litigation, mass torts, and corporate governance matters, including the representation of whistleblowers, shareholders and consumers in securities fraud, false claims act and class actions. Our lawyers have been responsible for recovering hundreds of millions of dollars for our clients throughout the United States, Africa, Asia and Europe. Visit our website to learn more about our firm.

SOURCE Kyros Law


These press releases may also interest you

at 03:01
Today, Planview® establishes a firm foothold in Lean and Agile with its acquisition of LeanKit. The addition of LeanKit's "Enterprise Kanban for Engineers" solution advances Planview's work and resource management (WRM) vision of supporting all the...

at 03:00
Medallia, Inc. (www.medallia.com) today announced it has been appointed by leading insurer Zurich to expand the use of Medallia Experience Cloudtm across its UK insurance business. The insurer is now implementing Medallia Experience Cloud across...

at 03:00
Clearbridge BioMedics today announced that its ClearCell® FX1 System is now broadly available in EMEA and APAC regions to complement its direct availability in the US and existing distribution channels. This was made possible through partnerships...

at 03:00
just-style, publisher and apparel consulting firm, is excited to announce the open beta of a new apparel sourcing tool, re:source, which hopes to address the need for more accessible information on trade and tariff data.      (Logo:...

at 02:00
Russell Reynolds Associates, a leading global search and leadership advisory firm, today announced it has agreed to acquire London-based Zygos Partnership, one of the UK's preeminent board and CEO advisory firms. The combination of Russell Reynolds...

at 02:00
Pluralsight, the enterprise technology learning company, today announced plans to open a new EMEA headquarters in Dublin in early 2018. The Dublin office will house the company's strategic business operations for the region and support its growing...




News published on 5 october 2017 at 19:46 and distributed by: